NCT05939700 - Mavacamten Pregnancy Surveillance Program | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 19, 2023

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions

BreastfeedingHypertrophic CardiomyopathyPregnancy Related

Interventions

DRUG

Mavacamten

Observational study of individuals exposed to at least 1 dose of mavacamten at any time during pregnancy and/or breastfeeding

Trial Locations (1)

RECRUITING

The Mavacamten Pregnancy Surveillance Program, PPD Inc, Wilmington